“Vertex Pharmaceuticals VRTX -0.02%decrease; red down pointing triangle has agreed to acquire Alpine Immune Sciences ALPN -0.01%decrease; red down pointing triangle for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up. The companies said Wednesday that Vertex would… Continue Reading…